Cargando…

Severe Ketoacidosis Associated with Canagliflozin (Invokana): A Safety Concern

Canagliflozin (Invokana) is a selective sodium glucose cotransporter-2 (SGLT-2) inhibitor that was first introduced in 2013 for the treatment of type 2 diabetes mellitus (DM). Though not FDA approved yet, its use in type 1 DM has been justified by the fact that its mechanism of action is independent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gelaye, Alehegn, Haidar, Abdallah, Kassab, Christina, Kazmi, Syed, Sinha, Prabhat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819091/ https://www.ncbi.nlm.nih.gov/pubmed/27088018 http://dx.doi.org/10.1155/2016/1656182

Ejemplares similares

Prolonged diabetic ketoacidosis associated with canagliflozin
por: Sloan, Gordon, et al.
Publicado: (2018)

Euglycemic Diabetic Ketoacidosis with Persistent Diuresis Treated with Canagliflozin
por: Adachi, Junichiro, et al.
Publicado: (2017)

Canagliflozin-associated Diabetic Ketoacidosis with Lower-than-anticipated Glucose Levels
por: Vadi, Sonali, et al.
Publicado: (2017)

Canagliflozin-associated diabetic ketoacidosis: a case report
por: Chai, Peter R., et al.
Publicado: (2017)

Canagliflozin-Induced Diabetic Ketoacidosis: Case Report and Review of the Literature
por: Turner, Jessica, et al.
Publicado: (2016)

Euglycemic diabetic ketoacidosis caused by canagliflozin: a case report
por: Fukuda, Masafumi, et al.
Publicado: (2020)

Euglycemic Diabetic Ketoacidosis With Prolonged Glucosuria Associated With the Sodium-Glucose Cotransporter-2 Canagliflozin
por: Kelmenson, Daniel A., et al.
Publicado: (2017)

SUN-700 Fournier’s Gangrene and Diabetic Ketoacidosis Caused by Canagliflozin
por: Stamatiades, George Alexiades, et al.
Publicado: (2020)

A Case of Euglycemic Diabetic Ketoacidosis Following Canagliflozin Therapy
por: Tuna, Kubra M, et al.
Publicado: (2021)

Ketoacidosis With Canagliflozin Prescribed for Phosphoinositide 3-Kinase Inhibitor–Induced Hyperglycemia: A Case Report
por: Bowman, Christopher, et al.
Publicado: (2017)

Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program
por: Erondu, Ngozi, et al.
Publicado: (2015)

MON-LB119 Euglycemic Diabetic Ketoacidosis in a Patient on Canagliflozin Presenting With Hypoglycemia
por: Inkollu, Sindhura, et al.
Publicado: (2020)

SUN-183 Prolonged Glycosuria after Canagliflozin Discontinuation in a Patient with Euglycemic Diabetic Ketoacidosis
por: Dai, Yufei, et al.
Publicado: (2019)

Efficacy and Safety of Canagliflozin in Kidney Transplant Patients
por: Shah, Mita, et al.
Publicado: (2019)

Euglycemic Diabetic Ketoacidosis Accompanied by Severe Hypophosphatemia During Recovery in a Patient With Type 2 Diabetes Being Treated With Canagliflozin/Metformin Combination Therapy
por: Shoukat, Sonia, et al.
Publicado: (2017)

Starvation Ketoacidosis: A Cause of Severe Anion Gap Metabolic Acidosis in Pregnancy
por: Sinha, Nupur, et al.
Publicado: (2014)

CANadian CAnagliflozin REgistry: Effectiveness and safety of canagliflozin in the treatment of type 2 diabetes mellitus in Canadian clinical practice
por: Woo, Vincent, et al.
Publicado: (2018)

Euglycemic Diabetic Ketoacidosis in a 27 year-old female patient with type-1-Diabetes treated with sodium-glucose cotransporter-2 (SGLT2) inhibitor Canagliflozin
por: Bader, Nimrah, et al.
Publicado: (2016)

Canagliflozin-associated severe hyponatremia: a rare and potentially adverse effect?
por: Dhanasekaran, Maheswaran, et al.
Publicado: (2022)

Severe hypertension in pediatric diabetic ketoacidosis a case report and review of literature
por: Zaki, Syed Ahmed, et al.
Publicado: (2022)

Severe hypercalcemia and hypernatremia in a patient treated with canagliflozin
por: Kaur, Arshpreet, et al.
Publicado: (2015)

Canagliflozin and Cardiovascular disease- results of the CANVAS trial
por: Shah, Syed Raza, et al.
Publicado: (2018)

Canagliflozin review – safety and efficacy profile in patients with T2DM
por: Jakher, Haroon, et al.
Publicado: (2019)

Canagliflozin – Beginning of the journey
por: Pandey, Sunil Kumar, et al.
Publicado: (2014)

A Case of Severe Acute Kidney Injury Exacerbated by Canagliflozin in a Patient with Type 2 Diabetes
por: Hassani-Ardakania, Kimya, et al.
Publicado: (2019)

Efficacy, safety and regulatory status of SGLT2 inhibitors: focus on canagliflozin
por: Haas, B, et al.
Publicado: (2014)

Euglycemic Ketoacidosis in Spinal Muscular Atrophy
por: Stoimenis, Dimitrios, et al.
Publicado: (2019)

Effects of canagliflozin on serum potassium in the CANagliflozin cardioVascular Assessment Study (CANVAS) Program
por: Weir, Matthew R, et al.
Publicado: (2020)

Crystal structure of canagliflozin hemihydrate
por: Liu, Kai-Hang, et al.
Publicado: (2016)

Severe allergic reaction to human insulin in the patient with diabetic ketoacidosis
por: Oray, Nese Colak, et al.
Publicado: (2017)

Respiratory failure in a diabetic ketoacidosis patient with severe hypophosphatemia
por: Choi, Han Saem, et al.
Publicado: (2018)

Severe Myopericarditis in Diabetic Ketoacidosis—All Troponin are Not Myocardial Infarction
por: Odubanjo, Anthony A, et al.
Publicado: (2018)

Acute post-operative diabetic ketoacidosis: Atypical harbinger unmasking latent diabetes mellitus
por: Haldar, Rudrashish, et al.
Publicado: (2016)

Tuberculous Meningitis Associated with Diabetic Ketoacidosis
por: Nalbantoğlu Elmas, Özlem, et al.
Publicado: (2011)

Euglycemic diabetic ketoacidosis associated with uremia
por: Zhang, Mingxia, et al.
Publicado: (2020)

Euglycemic Diabetic Ketoacidosis, a Misleading Presentation of Diabetic Ketoacidosis
por: Thawabi, Mohammad, et al.
Publicado: (2015)

Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease
por: Yale, J-F, et al.
Publicado: (2013)

Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus
por: Iijima, Hiroaki, et al.
Publicado: (2015)

Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus from India
por: Prasanna Kumar, K. M., et al.
Publicado: (2016)

Hypertriglyceridemia-induced acute pancreatitis with diabetic ketoacidosis: A rare presentation of type 1 diabetes mellitus
por: Kumar, Prabhat, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_c83ht30e7scq3k51621vlo1i2u